Join
Live feed
·
PRReleasevia Quantisnow
Zynerba Pharmaceuticals Inc. logo

Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE

ByQuantisnow·Wall Street's wire, on your screen.
ZYNE· Zynerba Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYNE (Zynerba Pharmaceuticals Inc.) and more on Quantisnow.